BRAoVO™ Plus Gene Panel

Genetic panel for breast, ovarian, prostate, pancreatic and colorectal cancer risk genes.

Test description

Testing for high and moderately high risk familial genes in cancer patients with a family history that includes any of breast, ovarian, colorectal, prostate or pancreatic cancers.

‍

Test information

Test name

BRAoVO™ Plus Cancer Gene Panel

‍

Clinical indication

Testing for patients with breast/ovarian/colorectal/prostate/pancreatic cancer where there is a mixed family history of these cancer types.

‍

Gene(s)

ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CDKN2A, CHEK2, EPCAM, HOXB13, MLH1, MSH2, MSH6, NF1, PALB2, PMS2, PTEN, RAD51C, RAD51D, STK11, TP53

‍

Method

Massively Parallel Sequencing

Turn around time

4 - 5 weeks

Medicare eligibility

73296 – conditions apply

‍73295 – conditions apply

‍73304 – conditions apply

Price

$575 if not Medicare eligible

Test request form

Cancer genetics test request form preferred. Standard pathology request form accepted.

Sample type

Blood x 2

Collection type

EDTA tube

Special instructions

2 x Bloods taken at 10 minute intervals. Pre-test genetic counselling required. Patient to provide consent prior to testing.

FAQ

No items found.

Resources

No items found.